Headache News and Research RSS Feed - Headache News and Research

Researchers identify 38 independent genomic regions linked to migraine

Researchers identify 38 independent genomic regions linked to migraine

The results of the largest genetic study on migraine thus far were published online in the journal Nature Genetics today, June 20. The study was based on DNA samples of 375,000 European, American and Australian participants. Almost 60,000 of them suffer from migraine. [More]
Caribbean, African-born women more likely to be admitted at ICU during delivery

Caribbean, African-born women more likely to be admitted at ICU during delivery

Women born in the Caribbean or Africa are two times more likely to be admitted to an intensive care unit at the time of their delivery than Canadian-born women, a new study has found. [More]
Many children, young adults with migraines appear to have mild vitamin deficiencies

Many children, young adults with migraines appear to have mild vitamin deficiencies

A high percentage of children, teens and young adults with migraines appear to have mild deficiencies in vitamin D, riboflavin and coenzyme Q10 -- a vitamin-like substance found in every cell of the body that is used to produce energy for cell growth and maintenance. [More]
FDA approves Vaxchora for prevention of cholera

FDA approves Vaxchora for prevention of cholera

The U.S. Food and Drug Administration today approved Vaxchora, a vaccine for the prevention of cholera caused by serogroup O1 in adults 18 through 64 years of age traveling to cholera-affected areas. Vaxchora is the only FDA-approved vaccine for the prevention of cholera. [More]
Utah researchers find way to use power of protease to destroy budding AIDS virus

Utah researchers find way to use power of protease to destroy budding AIDS virus

When new AIDS virus particles bud from an infected cell, an enzyme named protease activates to help the viruses mature and infect more cells. That's why modern AIDS drugs control the disease by inhibiting protease. [More]
New drug for chronic migraine may reduce headache hours in few days

New drug for chronic migraine may reduce headache hours in few days

A new drug to prevent migraine was associated with fewer headache hours for people with chronic migraine within three to seven days after the first injection, according to a study published in the June 8, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology. [More]
Migraine drug has quick onset of action

Migraine drug has quick onset of action

The drug TEV-48125, shown to be effective for chronic migraine in a phase II trial, appears to work within 3 to 7 days of injection, researchers report. [More]
Study shows women with migraine history have rapid decline in estrogen levels

Study shows women with migraine history have rapid decline in estrogen levels

Researchers have long known that sex hormones such as estrogen play a role in migraine. But there's been little research on how that works. Do women with migraine have higher estrogen levels in general? Higher levels at the peak of the monthly cycle? [More]
Rome IV criteria helps diagnose, treat gastrointestinal conditions in children

Rome IV criteria helps diagnose, treat gastrointestinal conditions in children

A child feels nauseated all the time, but no medical test can find what is wrong. Or a child vomits regularly, but there's no illness or eating disorder to explain it. These, and other stomach and bowel-related problems with no obvious causes, are called functional gastrointestinal disorders. [More]
Additional drug treatment options to prevent migraine may offer hope to sufferers

Additional drug treatment options to prevent migraine may offer hope to sufferers

Preventing or shortening the duration of migraine attacks - established drug treatment options and those that could shape future therapies were discussed at the Congress of European Academy of Neurology in Copenhagen. [More]
Pharmacist suggests education as foremost strategy to control opioid abuse

Pharmacist suggests education as foremost strategy to control opioid abuse

Technologies that make it harder for people to abuse opioids - like doctoring pills so that they produce unpleasant side effects if broken, crushed or injected -- likely will have limited effectiveness in stemming the global epidemic of opioid abuse, according to Adam Kaye, a professor of pharmacy at University of the Pacific. [More]
First buprenorphine implant for opioid dependence treatment gets FDA approval

First buprenorphine implant for opioid dependence treatment gets FDA approval

The U.S. Food and Drug Administration today approved Probuphine, the first buprenorphine implant for the maintenance treatment of opioid dependence. Probuphine is designed to provide a constant, low-level dose of buprenorphine for six months in patients who are already stable on low-to-moderate doses of other forms of buprenorphine, as part of a complete treatment program. [More]
Exposing headache sufferers to pure-wavelength green light can lessen severity of migraines

Exposing headache sufferers to pure-wavelength green light can lessen severity of migraines

Most migraine and post-traumatic headache sufferers find their headaches get worse in light, leading them to quit their most fundamental daily tasks and seek the comfort of darkness. [More]
Magic mushroom compound may offer potential new way for antidepressant research

Magic mushroom compound may offer potential new way for antidepressant research

Psilocybin – a hallucinogenic compound derived from magic mushrooms – may offer a possible new avenue for antidepressant research, according to a new study published in The Lancet Psychiatry today. [More]
WHO/PAHO statement on Zika virus and the 2016 Rio Olympic and Paralympic Games

WHO/PAHO statement on Zika virus and the 2016 Rio Olympic and Paralympic Games

The World Health Organization (WHO) and the Pan American Health Organization (PAHO) recognize that athletes and visitors are seeking more information on the risks of Zika and ways to prevent infection while attending the 2016 Rio Olympic and Paralympic Games (5 August to 18 September 2016). [More]
GammaCore both effective and cost effective for the treatment of cluster headache

GammaCore both effective and cost effective for the treatment of cluster headache

A paper in the Journal of Headache and Pain reports that non-invasive stimulation of the vagus nerve (nVNS) is a cost effective therapy for cluster headache. These findings were based on reductions in medication use and improvements in quality of life. The publication also notes that further economic benefits would have been found had reduced visits to clinics been taken into account. [More]
Neos announces U.S. launch of Adzenys XR-ODT for ADHD

Neos announces U.S. launch of Adzenys XR-ODT for ADHD

Neos Therapeutics, Inc., a pharmaceutical company with a late‐stage pipeline of innovative extended-release (XR) product candidates for the treatment of attention-deficit/hyperactivity disorder (ADHD), today announced that Adzenys XR-ODT™ is in distribution channels and is now available to prescribe for patients with ADHD in the United States. [More]
Boehringer Ingelheim presents new data on OFEV® (nintedanib) in idiopathic pulmonary fibrosis (IPF)

Boehringer Ingelheim presents new data on OFEV® (nintedanib) in idiopathic pulmonary fibrosis (IPF)

New analyses presented at the American Thoracic Society’s 2016 annual conference (ATS 2016) further add to the efficacy and safety profile of OFEV® (nintedanib) in idiopathic pulmonary fibrosis (IPF). [More]
Important signs, symptoms of stroke that everyone should know

Important signs, symptoms of stroke that everyone should know

Almost 795,000 Americans suffer from stroke each year, 130,000 which are fatal, making stroke the fifth leading cause of death in the United States. [More]
BetterYou Magnesium Oil spray relieves migraine pain in 43-year old mum

BetterYou Magnesium Oil spray relieves migraine pain in 43-year old mum

A 43-year old mum of one from Bristol, who suffered from frequent painful migraines for almost a decade has found relief thanks to BetterYou™ Magnesium Oil spray. [More]
Advertisement
Advertisement